System Transmission

Top Signal

100#1 JOB

Activity

2182Ripe

+938 today

System

Livenow

Terminal Asset View

stockNASDAQ

DSGN

$10.12+1.00%

Design Therapeutics Inc

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

74Ripe

Live Analysis Active

Company Mission

Design Therapeutics creates experimental medicines that target the genetic causes of rare diseases. Their treatments aim to fix problems at the DNA level for patients with specific inherited conditions. The company makes money through research funding and by partnering with larger drug companies to develop and potentially sell these therapies.

DSG

Industry Context

The biotechnology industry focuses on developing treatments using biological systems. Companies in this space research new medicines, often for specific diseases, and work to get them approved for patient use. This sector can see significant interest when new scientific approaches show promise.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

90Matrix

Market Momentum

49.3— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.6x— Normal Volume

Today's Change

1.00%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing DSGN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:20 PM UTC

As-of 03-15-2026 18:04 UTC

Develops drugs for genetic diseases and makes money by selling treatments to patients through healthcare providers.

Technical squeeze detected near recent price levels, suggesting potential breakout as buying and selling pressure builds.

Biotech sector showing increased interest in genetic therapies, which could benefit companies developing treatments for rare diseases.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...